Td Private Client Wealth LLC Novavax Inc Transaction History

Td Private Client Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 16, 2024	SELL	$69.73 - $142.9 $209 - $428	-3 Closed	0 $0
Q4 2021 Aug 16, 2024	SELL	$134.56 - $217.97 $807 - $1,307	-6 Reduced 66.67%	3 $429,000
Q3 2021 Aug 16, 2024	BUY	$177.8 - $270.58 $1,600 - $2,435	9 New	9 $1.87 Million
Q2 2021 Aug 16, 2024	BUY	$121.0 - $257.67 $1,452 - $3,092	12 New	12 $2.55 Million

288

85.3M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $697M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.